ArticleBMC veterinary research2025
Acremonium terricola culture supplementation in the diet of pregnant and lactating Ewes can improve the production performance of Ewes and lambs by regulating maternal metabolism and antibody delivery.
Article in BMC veterinary research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundThe fungal culture of Acremonium terricola culture (ATC) has been extensively utilized in livestock farming systems due to its demonstrated efficacy in improving productivity and preventing disease outbreaks. However, the effects of dietary ATC supplementation on pregnant and lactating ewes and their offspring remain a critical knowledge gap requiring investigation. Therefore, this study was designed to address two primary objectives: (1) to evaluate the effects of dietary supplementation with ATC on production performance and hematological parameters in ewes; (2) to determine whether maternally ingested ATC can be transmitted to offspring via lactation and subsequently influence lamb growth performance. This study employed eighteen ewes randomly stratified into two groups: a basal diet control (CON, n = 9) and an experimental group receiving basal diet supplementation with 9 g of ATC per ewe daily (ATC, n = 9). The study design comprised a 115-day protocol consisting of a 10-day pre-experimental acclimatization phase with environmental parameter standardization, followed by a 105-day controlled experimental intervention period.
resultsThe findings demonstrated that administration of ATC supplemented diets throughout the gestational-lactational period significantly enhanced maternal dry matter intake (DMI) and late-gestation (day 145) body mass (p < 0.05), concurrently attenuating gestational lipolysis compared with control group. Regarding lactation performance, ATC supplementation led to an increase in the average daily milk yield (0.90 vs. 0.78 kg/d), decelerated the decline rate of the lactation peak, and enhanced milk quality by boosting the percentages of milk fat, total solids (Ts), and urea content (p < 0.05). Moreover, ATC supplementation elevated serum levels of immunoglobulin A (IgA), urea, and superoxide dismutase (SOD) in pregnant and lactating ewes, while decreasing the interleukin-6 (IL-6) level (p < 0.05). For lambs, the supplementation of ATC in ewes' diets significantly improved the average daily gain (ADG) during the 1-45-day nursing period (p < 0.05) and showed a trend toward increased weaning weight at 45 days of nursing (p = 0.061). Biochemically, lambs from the ATC - supplemented group exhibited significantly higher serum concentrations of urea, IgA, interleukin-4 (IL-4), catalase (CAT), SOD, and total antioxidant capacity (T-AOC), along with lower serum tumor necrosis factor-α (TNF-α) content (p < 0.05).
conclusionsMaternal dietary supplementation with ATC demonstrated dual zootechnical benefits, effectively augmenting ovine productive efficiency through enhanced milk synthesis capacity, improving the immune and antioxidant levels of the body, while concurrently stimulating neonatal development of pre-weaning growth velocity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.